[1] 马榕, 张凯. 乳腺癌行腋窝淋巴结清扫规范、争议与共识[J]. 中国实用外科杂志, 2015, 35(1):69-71. [2] 何红梅,弥曼,李雪萍,等.乳腺癌的危险因素研究进展[J].中国妇幼健康研究,2016, 27(1):126-128. [3] Giuliano A E, Hunt K K, Ballman K V, et al.Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial[J]. JAMA, 2011, 305(6):569-575. [4] Yazdi H R, Movafagh A, Fallah F, et al.Evaluation of Methylobacterium radiotolerance and Sphyngomonas yanoikoaie in sentinel lymph nodes of breast cancer cases[J]. Asian Pac J Cancer Prev, 2016, 17(s3):279-285. [5] Maimaitiaili A, Wu D, Liu Z, et al.Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node positive Chinese breast cancer patients[J]. Cancer Biol Med, 2018,15(3): 282-283. [6] 张涛,施宝民,王洪,等.乳腺癌前哨淋巴结阳性时非前哨淋巴结转移的相关因素分析[J].外科研究与新技术,2017,6(1),1-4. [7] Zhang L, Huang Y, Yang C, et al.Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study[J]. World J Surg Oncol, 2018, 16(1):112. [8] Kohrt H E, Olshen R A, Bermas H R, et al.New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients[J]. BMC Cancer, 2008, 8(1):66-68. [9] Chue K M, Yong W S, Thike A A, et al.Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram[J]. J Clin Pathol, 2014, 67(2):112-119. [10] Nguyen T T, Hoskin T L, Day C N, et al.Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy[J]. Ann Surg Oncol, 2018, 25(9): 2596-2602. [11] 王文彦,王昕,王杰,等.乳腺癌低负荷前哨淋巴结阳性对非前哨淋巴结转移的预测分析[J]. 中华内分泌外科杂志, 2016, 10(2):144-147. [12] 未灯辉,许志宏,谢莉莉,等.前哨淋巴结微转移与乳腺癌复发风险的系统评价及Meta分析[J]. 中华普通外科学文献, 2019, 13(1):80-84. [13] Ding J, Jiang L, Wu W.Predictive value of clinico-pathological characteristics for sentinel lymph node metastasis in early breast cancer[J]. Med Sci Monitor ,2017, 23(25):4102-4108. [14] 邓李蓉,高元喜,邓艳芳.Ki67在乳腺癌中的表达水平及其对新辅助化疗患者预后的评估价值[J].实用癌症杂志, 2018,33(4),553-555. [15] Tvedskov T F, Jensen M, Balslev E, et al.Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node[J]. Acta Oncol, 2014, 53(2):209-215. |